Search Results - Christopher Longshaw

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Predicting early appropriate therapy for patients infected by carbapenem-resistant Gram-negative pathogens in intensive care units in Italy by Matteo Bassetti, Gianpaola Monti, Anne Santerre Henriksen, Christopher Longshaw

    Get full text
    Article


  2. 2

    Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of <i>Acinetobacter baumannii</i> Clinical Isolates by Clara Ballesté-Delpierre, Ángel Ramírez, Laura Muñoz, Christopher Longshaw, Ignasi Roca, Jordi Vila

    Published in Antibiotics (2022-01-01)
    Get full text
    Article


  3. 3

    In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014−2018 studies in Spain by Emilia Cercenado, Laura Cardenoso, Rocio Penin, Christopher Longshaw, Anne Santerre Henriksen, Alvaro Pascual

    Published in Journal of Global Antimicrobial Resistance (2021-09-01)
    Get full text
    Article


  4. 4

    In vitro activity of cefiderocol against European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations by Anne Santerre Henriksen, Fabio Arena, Marie Attwood, Rafael Canton, Sören Gatermann, Thierry Naas, Ian Morrissey, Christopher Longshaw

    Published in Microbiology Spectrum (2024-08-01)
    Get full text
    Article


  5. 5

    In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium by Saoussen Oueslati, Pierre Bogaerts, Laurent Dortet, Sandrine Bernabeu, Hend Ben Lakhal, Christopher Longshaw, Youri Glupczynski, Thierry Naas

    Published in Antibiotics (2022-10-01)
    Get full text
    Article


  6. 6

    In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor... by Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D. Perry, Mathias W. Pletz, Stefania Stefani, Ian Morrissey, Christopher Longshaw

    Published in Microbiology Spectrum (2024-04-01)
    Get full text
    Article


  7. 7

    The impact of commercially available media on cefiderocol susceptibility testing by broth microdilution method by Boudewijn L.M. DeJonge, Christine Slover, Sean T. Nguyen, Christopher Longshaw, Miki Takemura, Naomi Anan, Hidenori Yamashiro, Yoshinori Yamano

    Published in Journal of Clinical Microbiology (2025-09-01)
    Get full text
    Article


  8. 8

    Heteroresistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii in the CREDIBLE-CR study was not linked to clinical outcomes: a post hoc analysis by Christopher Longshaw, Anne Santerre Henriksen, Dana Dressel, Michelle Malysa, Christian Silvestri, Miki Takemura, Yoshinori Yamano, Takamichi Baba, Christine M. Slover

    Published in Microbiology Spectrum (2023-12-01)
    Get full text
    Article


Search Tools: